Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

Author： Madan Ravi A   Mohebtash Mahsa   Schlom Jeffrey   Gulley James L  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.1, 2010-01, pp. : 19-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Denosumab as a promising novel bone-targeted agent in castration resistant prostate cancer

By Dellis Athanasios   Papatsoris Athanasios G  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 7-10

Informa Healthcare

Access to resources Recommend Favorite

Prostate-specific antigen vaccines for prostate cancer

By Hörig Heidi   Lee Christopher SD   Kaufman Howard L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 395-408

Informa Healthcare

Access to resources Recommend Favorite

Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention

By Gerner E. W.   Meyskens F. L.   Goldschmid S.   Lance P.   Pelot D.  

Amino Acids, Vol. 33, Iss. 2, 2007-08 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Vaccines of the Future: From Rational Design to Clinical Development

By Souza Ana O De   Silva Celio L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 219-222

Informa Healthcare

Access to resources Recommend Favorite

Design of multi-epitope, analogue-based cancer vaccines

By Fikes John D   Sette Alessandro  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 6, 2003-09 ,pp. : 985-993

Informa Healthcare

Access to resources Recommend Favorite